Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Return on Assets (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Return on Assets for 11 consecutive years, with 0.79% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 95.0% to 0.79% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.79%, a 95.0% decrease, with the full-year FY2024 number at 0.55%, down 77.0% from a year prior.
  • Return on Assets was 0.79% for Q3 2025 at Marker Therapeutics, up from 0.92% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.32% in Q4 2023 to a low of 0.92% in Q2 2025.
  • A 5-year average of 0.36% and a median of 0.46% in 2021 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: soared 73bps in 2023, then plummeted -97bps in 2024.
  • Marker Therapeutics' Return on Assets stood at 0.56% in 2021, then soared by 39bps to 0.34% in 2022, then soared by 193bps to 0.32% in 2023, then tumbled by -304bps to 0.65% in 2024, then dropped by -21bps to 0.79% in 2025.
  • Per Business Quant, the three most recent readings for MRKR's Return on Assets are 0.79% (Q3 2025), 0.92% (Q2 2025), and 0.65% (Q1 2025).